Opendata, web and dolomites

HemaXis DX SIGNED

A patient-friendly blood collection device that produces pure plasma samples for simple laboratory analysis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HemaXis DX project word cloud

Explore the words cloud of the HemaXis DX project. It provides you a very rough idea of what is the project "HemaXis DX" about.

proteins    abnormal    clinical    drops    clotting    uses    chain    supply    unlike    professionals    finalize    dbs    performed    engineering    time    microfluidics    technician    scaling    diagnostic    amount    contains    procedure    check    certain    market    routinely    significantly    volume    painless    dissolved    venepuncture    mineral    hormones    tested    liquid    minimal    sodium    invasive    collection    single    haemoglobin    strategy    yearly    manner    blood    prepared    fingertip    skilled    dried    attain    1950    undertaken    plasma    spot    minimally    accurate    droplets    undoubtedly    seconds    fast    annually    tools    ions    tests    preparation    outdated    dx    precisely    point    millions    healthcare    tens    changed    techniques    analysed    levels    lab    plan    ready    finger    device    potassium    glucose    immediately    prick    regular    diagnose    drugs    samples    routine    industrialization    medical    extract    consuming    laboratory    collecting    drafted    collect    prepare    innovation    powerful    clinician    costly    hemaxis   

Project "HemaXis DX" data sheet

The following table provides information about the project.

Coordinator
DBS SYSTEM SA 

Organization address
address: ROUTE DES AVOUILLONS 6
city: GLAND
postcode: 1196
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Project website http://hemaxis.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2019-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DBS SYSTEM SA CH (GLAND) coordinator 50˙000.00

Map

 Project objective

Blood analysis is undoubtedly one of the most powerful medical diagnostic tools. In most cases, blood tests are often a part of regular check-up undertaken yearly to diagnose certain abnormal values, such as low haemoglobin or high/low sodium or potassium levels. In Europe tens of millions of blood tests are performed annually. Blood collection techniques have not significantly changed since 1950’s: venepuncture is the most routinely performed procedure and skilled healthcare professionals and complex procedures to attain adequate blood samples are still required. In addition to an outdated process, before the blood is tested, it needs to be precisely prepared for analysis. Most routine laboratory tests are performed on plasma, which is the liquid component of blood which contains dissolved proteins, glucose, clotting factors, mineral ions, hormones and drugs. However, the preparation of the blood plasma is a time consuming and costly process. HemaXis DX is a dried blood plasma spot device which uses microfluidics technology to collect and prepare accurate volume of controlled samples of plasma immediately ready to be analysed in laboratory allowing sample preparation directly at the point of collection. HemaXis DX allows the clinician/lab technician to collect the required drops of blood from the fingertip in a minimally invasive, fast and painless manner. Unlike the traditional venepuncture, this method of collecting blood does not result in any side effects. A simple finger prick is needed to extract a minimal amount of blood in single droplets in a matter of seconds. During the phase 1 project, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. Within the overall innovation project DBS System will finalize its engineering of HemaXis DX before scaling up for clinical studies and system industrialization.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HEMAXIS DX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HEMAXIS DX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

C-Air (2018)

An innovative, reliable, lifesaving industrial air purification system that contains, cleans, and purifies air contaminated by toxic gases.

Read More  

Presque (2019)

Smart Nursing Bra

Read More  

PAROST (2019)

Disruptive technology for the identification, quantification and prediction of the evolution of damages in civil engineering structures that increases safety while reducing maintenance costs.

Read More